Premium
TIMOLOL MALEATE IN THE TREATMENT OF GLAUCOMA SIMPLEX AND GLAUCOMA CAPSULARE A three‐year follow up study
Author(s) -
BLIKA SIGMUND,
SAUNTE ELDBJØRG
Publication year - 1982
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.1982.tb00629.x
Subject(s) - glaucoma , timolol , medicine , ophthalmology , open angle glaucoma , intraocular pressure
180 eyes of 97 patients with primary open angle glaucoma and IOP > 22 mm were treated for more than 3 years with timolol‐maleate. 130 eyes had glaucoma simplex, and 50 eyes had glaucoma capsulare. With timolol maleate as the only medication after 3 years, the IOP was controlled in 33% of the glaucoma simplex group, and in 8% of the glaucoma capsulare group. No serious local or systemic side‐effects were observed.